Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/44893
Title: | Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment |
Authors: | BELDA, W.; PASSERO, L. F. Domingues; CASOLATO, A. T. Stradioto |
Citation: | CASE REPORTS IN DERMATOLOGICAL MEDICINE, v.2021, article ID 9453701, p, 2021 |
Abstract: | Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions caused by infected cats play an important role in the epidemiology of the disease. The classic treatment of sporotrichosis is performed with itraconazole or potassium iodide; second-line medications, such as amphotericin B and terbinafine, can alternatively be used in cases of first-line drug failure. In the present study, a patient with lymphocutaneous sporotrichosis in the right upper limb exhibited intolerance to itraconazole and potassium iodide, additionally during the period of use; these drugs did not control skin lesions. In this patient, amphotericin B deoxycholate and its liposomal version were used in this patient; and complete recovery of the lesions was observed. © 2021 Walter Belda et al. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MDT Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/50 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_BELDA_Lymphocutaneous_Sporotrichosis_Refractory_to_FirstLine_Treatment_2021.PDF | publishedVersion (English) | 2.77 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.